CBOE vs HBAN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CBOE exhibits a stable financial profile with a Piotroski F-Score of 4/9 and a strong balance sheet characterized by low debt/equity (0.31). While the stock is trading near its growth-based intrinsic value of $307.39, it is significantly overpriced relative to its defensive Graham Number of $107.29. Exceptional earnings growth (60.5% YoY) and a consistent track record of earnings beats are offset by a high PEG ratio (3.75) and bearish short-term signals. The convergence of a 'Hold' analyst consensus, bearish insider activity, and a weak technical trend suggests the stock is currently fully valued.
HBAN presents a mixed profile with a stable Piotroski F-Score of 4/9 and a Graham Number of $20.76 suggesting significant defensive undervaluation relative to its current price of $16.38. While the bank maintains a healthy dividend payout ratio and consistent historical earnings beats, there is a concerning divergence between revenue growth (+10.30%) and earnings growth (-10.90%). The technical trend is currently bearish (0/100), and the intrinsic growth-based value ($9.73) suggests the market is pricing in premiums that the current earnings trajectory does not fully support.
Compare Another Pair
Related Comparisons
CBOE vs HBAN: Head-to-Head Comparison
This page compares Cboe Global Markets, Inc. (CBOE) and Huntington Bancshares Incorporated (HBAN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.